Physician

Amar N Khurana, MD

According to 2025 Medicare claims, Amar Khurana, MD (NPI: 1114914280) practices internal medicine in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Hancock, WV. This provider's primary affiliated billing organization is WMC PHYSICIAN PRACTICES LLC (NPI: 1518303288; TIN: 461883875) and primary practice location at 26062-5012.

Khurana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 3,401 HCPCS/CPT codes, and received $144,704 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 15,307 prescription claims across 715 beneficiaries totaling $696,281 in drug costs, led by Eliquis (Apixaban). DME data shows 741 claims. Open Payments data shows 20 records totaling $709. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $250,221 to $144,704. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $58,278 and ending at $35,483.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	710	4,868	$250,221
2016	750	4,579	$220,211
2017	665	4,491	$212,718
2018	626	3,706	$169,728
2019	596	3,444	$158,649
2020	587	3,130	$141,229
2021	604	3,159	$159,125
2022	581	3,094	$155,936
2023	539	2,644	$149,815
2024	503	3,401	$144,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	533	14,152	$493,635
2016	645	16,538	$630,033
2017	685	17,194	$712,426
2018	702	17,146	$759,948
2019	670	16,489	$769,883
2020	735	16,071	$761,978
2021	724	15,511	$765,444
2022	728	16,014	$776,010
2023	737	16,839	$895,522
2024	715	15,307	$696,281

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	224	1,040	$57,040
2016	165	1,082	$38,451
2017	202	840	$18,832
2018	193	903	$26,744
2019	241	1,010	$42,795
2020	272	1,073	$72,378
2021	243	1,002	$60,033
2022	225	886	$46,926
2023	266	1,083	$61,743
2024	188	741	$43,997

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	120	162	$95
99239	Hospital discharge day management, more than 30 minutes	99	131	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	147	470	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	245	409	$48
G0444	Annual depression screening, 5 to 15 minutes	149	149	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	258	7,810	$149,617
Ozempic	Semaglutide	55	1,966	$61,771
Xarelto	Rivaroxaban	93	3,066	$55,904
Januvia	Sitagliptin Phosphate	29	1,710	$32,192
Mounjaro	Tirzepatide	25	812	$28,410

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	17	$16,003
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	17	131	$9,023
A7031	Face mask interface, replacement for full face mask, each	N	15	36	$3,387
A7030	Full face mask used with positive airway pressure device, each	N	13	32	$2,644
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,750

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$709	Inari Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amar N. Khurana, MD?

Tedicare shows public-source Medicare data for Amar N. Khurana, MD (NPI 1114914280), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amar N. Khurana, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amar N. Khurana, MD?

Amar N. Khurana, MD is linked to WMC PHYSICIAN PRACTICES LLC (billing NPI 1518303288) in the available physician profile data.

Does Amar N. Khurana, MD have Open Payments data?

Amar N. Khurana, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.